---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-183292"
form_type: "8-K"
ticker: "ENGN"
cik: "0001980845"
company_name: "enGene Therapeutics Inc."
filed_at: "2024-07-24T23:59:59+00:00"
generated_at: "2026-05-31T17:35:03.464959+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# enGene appoints Ron Cooper as CEO, promotes Raj Pruthi to CMO; Hanson departs as planned

## Summary
- Ron Cooper appointed CEO and director effective July 22, 2024; Jason Hanson resigns but remains as strategic advisor.
- Cooper receives $700k base salary, 60% bonus target, and inducement option for 1.25M shares at $8.81, vesting over 4 years.
- Raj Pruthi promoted to CMO succeeding Richard Bryce, who departed July 19, 2024.
- Hanson's transition amendment provides $390k severance payment; retains consulting role at $25k/month for 6 months.

## SEC filing metadata
- accession: 0001193125-24-183292
- form_type: 8-K
- ticker: ENGN
- cik: 0001980845
- company_name: enGene Therapeutics Inc.
- filed_at: 2024-07-24T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1980845/000119312524183292/0001193125-24-183292-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1980845/000119312524183292/d597787d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-183292
- JSON: https://secwatch.observer/filing/0001193125-24-183292.json
- Plain text: https://secwatch.observer/filing/0001193125-24-183292.txt

## Key facts
- Executive change
  Jason D. Hanson resigned as Chief Executive Officer at enGene Therapeutics Inc..
  - Action: resigned
  - Role: Chief Executive Officer
  source text: Mr. Hanson’s separation from the Company and resignation as a director became effective July 21, 2024, and his resignation is not the result of any disagreement with the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1980845/000119312524183292/0001193125-24-183292-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.